Description
Tesamorelin is a synthetic GHRH analogue stabilised with a trans-3-hexenoic acid modification at the N-terminus, improving enzymatic stability versus native GHRH. It stimulates pulsatile GH secretion through GHRH receptor activation in somatotroph cells and is studied in models of visceral adipose tissue regulation, IGF-1 production, and lipid metabolism in the context of GH deficiency states.
Available as 2 mg, 5 mg, 10 mg, and 20 mg lyophilized at ≥98% HPLC purity. COA included.
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| CAS | 218949-48-9 |
| MW | 5135.8 g/mol |
Research Use Only. Not for human or veterinary use.
